Should we still use phototherapy for pityriasis rosea?

Photodermatology Photoimmunology and Photomedicine

Volumn 19, Issue 3, 2003, Pages 160-161

  Castanedo Cazares, Juan Pablo ^a   Lepe, Veronica ^a   Moncada, Benjamin ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CORTICOSTEROID DERIVATIVE;

ADULT; ANTIVIRAL ACTIVITY; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; ERYTHEMATOSQUAMOUS SKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; LETTER; MALE; PHOTOTHERAPY; PITYRIASIS ROSEA; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION;

ACYCLOVIR; ADOLESCENT; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PHOTOTHERAPY; PITYRIASIS ROSEA; THORAX;

EID: 0038379832     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2003.00029.x     Document Type: Letter

References (6)

1. Yoshida M, Yamada M, Tsukazaki T, et al. Comparison of anti-viral compounds against human herpesvirus 6 and 7. Antiviral Res 1998; 40: 73-84.
2. Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 2002; 119: 793-797.
3. Leonforte JF. Pityriasis rosea: exacerbation with corticosteroid treatment. Dermatol 1981; 163: 480-481.
4. Horio T. Skin disorders that improve by exposure to sunlight. Clin Dermatol 1998; 16: 59-65.
5. Leenutaphong V, Jiamton S. UVB phototherapy for Pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol 1995; 33: 996-999.
6. Eslick GD. Atypical Pityriasis rosea or Psoriasis guttata? Early examination is the key to a correct diagnosis. Int J Dermatol 2002; 41: 788-791.